In vivo mapping of cortical amyloid beta‐myelin coupling in preclinical Alzheimer's disease
Alzheimer's & Dementia · 2026-03 · 22 (3)
DOI: 10.1002/alz.71268 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 04.03.2026. Verfasst von Mercedes Atienza und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Functional Neuroscience, Pablo de Olavide University, Seville, Spain. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Myelin Sheath, Cerebral Cortex. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Spanish Ministry of Science, Innovation and Universities, Junta de Andalucía, CIBERNED.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Accumulating evidence suggests that amyloid‐β (Aβ) preferentially deposits in poorly myelinated cortical regions and may interfere with remyelination. We hypothesized that this vulnerability would manifest as altered Aβ–myelin coupling in preclinical Alzheimer's disease (AD). METHODS We assessed spatial coupling between amyloid positron emission tomography (PET) and myelin content estimated from T1w/T2w ratio maps in 151 cognitively unimpaired older adults. Associations with preclinical AD, blood‐based biomarkers, resting‐state functional connectivity (rs‐FC), and subjective memory complaints (SMC) were examined. RESULTS Compared with controls, Aβ + individuals exhibited increased positive and negative Aβ–myelin coupling in late‐ and early‐myelinating regions, respectively, likely reflecting compensatory remyelination versus progressive myelin loss, along with disrupted rs‐FC and greater SMC. Serum glial fibrillary acidic protein (GFAP) and plasma phosphorylated tau at threonine 181 (pTau‐181) showed differential, region‐specific associations with Aβ–myelin coupling, with GFAP partially mediating tau‐related effects. Exploratory stratification suggested distinct biomarker profiles linked to the direction of coupling dominance, potentially reflecting different preclinical AD phases. DISCUSSION Aβ–myelin coupling may represent a sensitive, stage‐dependent marker of early AD–related cortical pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Functional Neuroscience, Pablo de Olavide University, Seville, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Förderung
- Spanish Ministry of Science, Innovation and Universities
- Junta de Andalucía
- CIBERNED
Zitieren
APA
Atienza, M., & Cantero, J. L. (2026). In vivo mapping of cortical amyloid beta‐myelin coupling in preclinical Alzheimer's disease. Alzheimer's & Dementia, 22(3). https://doi.org/10.1002/alz.71268
Vancouver
Atienza M, Cantero JL. In vivo mapping of cortical amyloid beta‐myelin coupling in preclinical Alzheimer's disease. Alzheimer's & Dementia. 2026;22(3). doi:10.1002/alz.71268
BibTeX
@article{Atienza2026,
author = {Atienza, Mercedes and Cantero, Jose L},
title = {In vivo mapping of cortical amyloid beta‐myelin coupling in preclinical Alzheimer's disease},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {3},
doi = {10.1002/alz.71268}
}
EUVIMED